BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30870495)

  • 1. Systemic nature of spinal muscular atrophy revealed by studying insurance claims.
    Lipnick SL; Agniel DM; Aggarwal R; Makhortova NR; Finlayson SG; Brocato A; Palmer N; Darras BT; Kohane I; Rubin LL
    PLoS One; 2019; 14(3):e0213680. PubMed ID: 30870495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies.
    Karakaya M; Storbeck M; Strathmann EA; Delle Vedove A; Hölker I; Altmueller J; Naghiyeva L; Schmitz-Steinkrüger L; Vezyroglou K; Motameny S; Alawbathani S; Thiele H; Polat AI; Okur D; Boostani R; Karimiani EG; Wunderlich G; Ardicli D; Topaloglu H; Kirschner J; Schrank B; Maroofian R; Magnusson O; Yis U; Nürnberg P; Heller R; Wirth B
    Hum Mutat; 2018 Sep; 39(9):1284-1298. PubMed ID: 29858556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients.
    Dastur RS; Gaitonde PS; Khadilkar SV; Udani VP; Nadkarni JJ
    Neurol India; 2006 Sep; 54(3):255-9. PubMed ID: 16936383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy.
    D'Amico A; Mercuri E; Tiziano FD; Bertini E
    Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of full-length mRNA for cBCD541 does not correlate with spinal muscular atrophy phenotype severity.
    Nishio H; Ishikawa Y; Lee MJ; Fujii M; Kanda F; Jinnai K; Takahashi K; Takeshima Y; Wada H; Takada S; Nakamura H; Matsuo M; Sumino K
    Neurology; 1997 May; 48(5):1266-70. PubMed ID: 9153454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term exercise-specific neuroprotection in spinal muscular atrophy-like mice.
    Chali F; Desseille C; Houdebine L; Benoit E; Rouquet T; Bariohay B; Lopes P; Branchu J; Della Gaspera B; Pariset C; Chanoine C; Charbonnier F; Biondi O
    J Physiol; 2016 Apr; 594(7):1931-52. PubMed ID: 26915343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan.
    Okamoto K; Motoki T; Saito I; Urate R; Aibara K; Jogamoto T; Fukuda M; Wakamoto H; Maniwa S; Kondo Y; Toda Y; Goji A; Mori T; Soga T; Konishi Y; Nagai S; Takami Y; Tokorodani C; Nishiuchi R; Usui D; Ando R; Tada S; Yamanishi Y; Nagai M; Arakawa R; Saito K; Nishio H; Ishii E; Eguchi M
    Brain Dev; 2020 Sep; 42(8):594-602. PubMed ID: 32505480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of SMN in Schwann cells reverses myelination defects and improves neuromuscular function in spinal muscular atrophy.
    Hunter G; Powis RA; Jones RA; Groen EJ; Shorrock HK; Lane FM; Zheng Y; Sherman DL; Brophy PJ; Gillingwater TH
    Hum Mol Genet; 2016 Jul; 25(13):2853-2861. PubMed ID: 27170316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    DU J; Qu YJ; Xiong H; Li EZ; Jin YW; Bai JL; Wang H; Song F
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):411-5. PubMed ID: 21924051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein.
    Otsuki N; Arakawa R; Kaneko K; Aoki R; Arakawa M; Saito K
    PLoS One; 2018; 13(8):e0201764. PubMed ID: 30102724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
    Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
    J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
    Nash LA; Burns JK; Chardon JW; Kothary R; Parks RJ
    Curr Mol Med; 2016; 16(9):779-792. PubMed ID: 27894243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls.
    Wadman RI; Stam M; Jansen MD; van der Weegen Y; Wijngaarde CA; Harschnitz O; Sodaar P; Braun KP; Dooijes D; Lemmink HH; van den Berg LH; van der Pol WL
    PLoS One; 2016; 11(11):e0167087. PubMed ID: 27893852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
    Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.